Ani Pharmaceuticals reported $61.68M in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Ani Pharmaceuticals ANIP:US $ 61.68M 5.95M
Aurora Cannabis Inc ACB:CN 155.82M 18.1M
Biodelivery Sciences International BDSI:US $ 23.08M 4.42M
Canopy Growth Corp WEED:CN C$ 86.9M 324.77M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Emergent Biosolutions EBS:US $ 364.6M 21.8M
Endo International Ordinary Shares ENDP:US $ 297.3M 41.15M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Hikma Pharmaceutical HIK:LN 736M 21M
Knight Therapeutics Inc GUD:CN C$ 74.91M 19.13M
Lannett LCI:US $ 112.64M 3.09M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Omeros OMER:US $ 712K 266K
Perrigo Ordinary Shares PRGO:US $ 1092.5M 23.4M
Teva Pharmaceutical TEVA:IT 4.17B 195M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M